Higher Eicosapentaenoic Acid Research Articles

Low sucrose diets protect long-term memory and EPA & DHA enriched diets alter insulin resistance in a mouse model of chemotherapy

Chemotherapy-related cognitive impairment (CRCI) and affective symptoms negatively impact quality of life in breast cancer survivors. The aim of this study was to determine the efficacy of high eicosapentaenoic acid + docosahexaenoic acid (EPA+DHA) and low sucrose diets to alleviate these symptoms in a mouse model of chemotherapy. Potential mechanisms involving insulin resistance were explored. We hypothesized that diets enriched in EPA+DHA and low amounts of sucrose would protect against the impact of chemotherapy on measures of CRCI. Female C57Bl/6 mice were randomized to 1 of 4 diets (2% kcal eicosapentaenoic acid + docosahexaenoic acid [EPA+DHA]/high or low sucrose, low omega-3/high or low sucrose) for 6 weeks and treated with two injections of doxorubicin-based chemotherapy or vehicle during week 2 and 4. Behavioral tests were performed 7 days after second injection. Chemotherapy increased serum insulin and decreased body weight, locomotion and exploratory behavior (all p < .05). Low sucrose consumption resulted in better long-term memory regardless of chemotherapy or vehicle injection (p < .05). 2% EPA+DHA consumption lessened insulin resistance (p < .05); however, controlling for body weight attenuated this effect (p = .08). There were no significant differences by diet or injection on liver lipid content; however, liver lipid content was positively correlated with insulin resistance scores (p < .05). Low sucrose diets may protect long-term memory during chemotherapy. The effect of EPA+DHA on insulin resistance and affective side effects during chemotherapy requires further investigation.

Association of serum fatty acid pattern with depression in U.S. adults: analysis of NHANES 2011–2012

BackgroundExposure to different concentration levels of fatty acids (FAs) may have an impact on depression. However, previous studies using individual FAs may not reflect the performance of mixtures of various FAs, and the associations of FA patterns with depression remain unclear.MethodsWe conducted the cross-sectional analysis in 792 adults aged 18 and older with available serum FAs and depression screening data in the National Health and Nutrition Examination Survey (NHANES) 2011–2012. The serum concentrations of thirty FAs were measured using gas chromatography-mass spectrometry and their percentage compositions were subsequently calculated. Depression was defined as the Patient Health Questionnaire-9 score ≥ 10. We employed principal component analysis to derive serum FA patterns. We examined the association between these patterns and depression in the overall population and various subgroups through survey-weighted logistic regression.ResultsFour distinct patterns of serum FAs were identified: ‘high eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA); low docosatetraenoic acid (DTA) and docosapentaenoic acid (DPA) n-6’, ‘high long-chain saturated FA and long chain FA’, ‘low median-chain saturated FA and myristoleic acid’ and ‘low capric acid and lauric acid; high gamma-linolenic acid (GLA) and stearidonic acid (SDA)’ pattern. Individuals in the high tertile of ‘high EPA and DHA; low DTA and DPA n-6’ pattern score had 0.46 (95% CI: 0.22, 0.93) lower odds of developing depression compared to individuals in the lowest tertile after adjusting for confounders such as age, sex, physical activity and total energy intake, etc. The odds ratio (OR) of depression was increased in the population with the highest tertile of ‘low capric acid and lauric acid; high GLA and SDA’ pattern (OR: 2.45, 95% CI: 1.24, 4.83). In subgroup analyses, we observed that the association between ‘high EPA and DHA; low DTA and DPA n-6’ and depression persisted among specific demographic and lifestyle subgroups, including females, non-Mexican Americans, non-obese, those aged over 60 years, smokers and drinkers. Similarly, ‘low capric acid and lauric acid; high GLA and SDA’ showed stable associations in female, non-Mexican Americans and smokers.ConclusionsSerum FA patterns are associated with depression, and their relationships vary across sex, race, BMI, age, smoking and drinking subgroups, highlighting the importance of considering specific FA patterns within these demographic and lifestyle categories. Utilization of combined FA administration may serve as a mitigation measure against depression in these specific populations.

Fatty Acids and Their Lipogenic Enzymes in Anorexia Nervosa Clinical Subtypes.

Disordered eating behavior differs between the restricting subtype (AN-R) and the binging and purging subtype (AN-BP) of anorexia nervosa (AN). Yet, little is known about how these differences impact fatty acid (FA) dysregulation in AN. To address this question, we analyzed 26 FAs and 7 FA lipogenic enzymes (4 desaturases and 3 elongases) in 96 women: 25 AN-R, 25 AN-BP, and 46 healthy control women. Our goal was to assess subtype-specific patterns. Lauric acid was significantly higher in AN-BP than in AN-R at the fasting timepoint (p = 0.038) and displayed significantly different postprandial changes 2 h after eating. AN-R displayed significantly higher levels of n-3 alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid (EPA), docosapentaenoic acid, and n-6 linoleic acid and gamma-linolenic acid compared to controls. AN-BP showed elevated EPA and saturated lauric acid compared to controls. Higher EPA was associated with elevated anxiety in AN-R (p = 0.035) but was linked to lower anxiety in AN-BP (p = 0.043). These findings suggest distinct disordered eating behaviors in AN subtypes contribute to lipid dysregulation and eating disorder comorbidities. A personalized dietary intervention may improve lipid dysregulation and enhance treatment effectiveness for AN.

Nutritional quality of fish oil extracted from selected freshwater fish species

There is increased consumer awareness of the nutritional importance of fish oil consumption in recent time, however there is paucity of information on the quality of oil obtained from freshwater fishes available in this study area. Nutritional quality of fish oil extracted from 9kg each of Chrysichthys nigrodigitatus, Synodontis membranaceous and Clarias gariepinus were investigated with the aim of providing baseline information on the nutritional quality of oil in the fish available around the study area. Wet rendering, soxhlet extraction and microwave assisted extraction methods were used. Data collected were subjected to appropriate statistical analysis using SPSS 6.0. version. S. membranaceous have the largest oil yield while C. nigrodigitatus have the lowest oil yield; wet rendering oil extraction method gave the highest oil yield. The physical quality characteristics of S. membranaceous was the best with the lowest melting point (28.73 ±0.39°C), specific gravity (0.11± 0.01) and refractive index (1.14 ±0.01) while C. gariepinus oil had the poorest physical quality characteristics. Oil of C. nigrodigitatus have better chemical qualities than the rest having the lowest saponification value (9.81±0.01 mg KOH/g), iodine value (1.59±0.01 gl/100g), acid value (1.12±0.01 mgKOH/g) and free fatty acid (0.56±0.01%) while C. gariepinus oil was the poorest. C. nigrodigitatus also have the highest polyunsaturated fatty acid (PUFA) (18.75), highest Ʃn-3 FA (23.45), highest DHA (Docosahexaenoic acid) (4.93), highest eicosapentaenoic acid EPA+DHA (7.8). The oils chemical qualities are in the order of C. nigrodigitatus> S. membranaceous> C. gariepinus and are of good quality. Oil obtained from C. nigrodigitatus is therefore recommended due to its good chemical qualities using wet rendering oil extraction method. Information provided in this study will guide industrialists and nutritionists on the best extraction method and fish that will give highest oil yield and best oil quality in the study area.

Optimum eicosapentaenoic acid + docosahexaenoic acid levels for farmed Atlantic salmon: closing the gap between science and commercial practice

The shift from fish oil to vegetable oil (VO) sources has lowered eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels in salmon aquafeeds. VOs are high in omega-6 and low in omega-3 essential fatty acids like EPA and DHA, crucial for fish metabolism and immunity. Algal oil (AO), with high EPA + DHA and lower omega-6 levels supports fish health and growth, but transferring lab-controlled conditions to real-world commercial farming remains a challenge. This study explored the benefits of high dietary EPA + DHA levels through a commercial farm (CF) study in Chile and a Big Data (BD) study in Norway. The CF study, involving 625,000 Atlantic salmon, compared standard feed with AO-supplemented feed. The latter resulted in improved health responses and better fillet quality. The BD study analyzed real data from 232.6 million fish, revealing that EPA + DHA levels &amp;gt; 8% reduce mortality variability by 21%, improve economic feed conversion ratio by 11%, and increase the likelihood of superior harvests by 27%, demonstrating productivity benefits. Both studies emphasize the advantages of feeds with EPA + DHA levels above typical industry practices, enhancing growth, health, and nutritional quality. Importantly, the BD study complements the CF study, bridging the gap between science and aquafarms, and providing evidence that diets with EPA + DHA &amp;gt; 8% offer biological performance benefits for farmers, regardless of farming environments.

Dual stress factors adaptive evolution for high EPA production in Schizochytrium sp. and metabolomics mechanism analysis.

Eicosapentaenoic acid (EPA) is a vital ɷ-3 polyunsaturated fatty acid (PUFA) for human body with various physiological functions. In this study, we proposed an adaptive evolutionary strategy based on high-temperature and high-oxygen two-factor stress to increase the EPA production capacity of Schizochytrium. High-temperature stress was used to increase EPA yield, and high oxygen was implemented to continuously stimulate cell growth and lipid accumulation. The biomass and EPA production of ALE-D50 reached 35.33g/L and 1.54g/L, which were 43.85% and 71.11% higher than that of the original strain, respectively. Lower in vivo reactive oxygen species levels indicated that the evolved strain possessed stronger antioxidant activity. Liquid chromatography-mass spectrometry metabolomics showed that enhanced glucose consumption and glycolysis metabolism, as well as a weakened tricarboxylic acid cycle and reduced amino acid metabolic tributaries in the evolved strain, might be associated with increased growth and EPA synthesis. Finally, the lipid production and EPA production in a fed-batch fermentation were further increased to 48.93g/L and 3.55g/L, improving by 54.30% and 90.86%, respectively. This study provides a novel pathway for promoting EPA biosynthesis in Schizochytrium.

Prognostic Significance of Sarcopenia and Eicosapentaenoic Acid (EPA) Levels in Patients With Unresectable Pancreatic or Biliary Tract Cancer.

This study aimed to investigate the relationship between prechemotherapy blood eicosapentaenoic acid (EPA) levels, sarcopenia, and overall survival in patients with pancreatic and biliary tract cancer undergoing chemotherapy. Forty-five patients with recurrent, non-resected pancreatic or biliary tract cancer undergoing chemotherapy were retrospectively analyzed. The skeletal muscle mass was measured at the third lumbar vertebra. Sarcopenia cut-off values were based on the Japanese Society of Hepatology sarcopenia assessment criteria. Two months after starting chemotherapy, the patients received enteral nutrition containing omega-3 fatty acids. Patients with pancreatic and biliary tract cancers with low pre-treatment blood EPA levels had significantly more intense sarcopenia than those with high EPA levels (p=0.023). Patients with sarcopenia before chemotherapy had significantly lower overall survival than those without sarcopenia. Multivariate analysis revealed blood EPA concentration as an independent prognostic factor (p<0.01). Lumbar muscle volume, a marker of sarcopenia, showed a clear positive correlation with prechemotherapy EPA concentration (p=0.008). In patients administered with enteral nutrition containing omega-3 fatty acids, both EPA concentration and lumbar muscle volume were significantly higher than those prior to intervention, indicating sarcopenia improvement due to the intervention. In patients with recurrent non-resected pancreatic and biliary tract cancer, low blood EPA levels before chemotherapy are associated with sarcopenia and poor prognosis.

Omega-3 Fatty Acids for Depression in the Elderly and Patients with Dementia: A Systematic Review and Meta-Analysis.

This study aimed to evaluate the efficacy of omega-3 fatty acid supplementation interventions in improving depression in patients with dementia. To achieve this objective, randomized controlled trials (RCTs) were identified from primary electronic databases, focusing on the relationship between omega-3 fatty acids and depression in patients with dementia. The primary outcome was the impact of omega-3 fatty acids on post-intervention depression in patients with dementia, with subgroup analyses conducted based on the type of intervention (docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) combination), duration of intervention (3 months, 6 months, 12 months, ≥24 months), cognitive function (ranging from mild cognitive impairment (MCI) to severe dementia), and daily dosage (high, medium, low, applicable to both DHA and EPA). The study has been duly registered with PROSPERO (registration ID: CRD42023408744). A meta-analysis of five studies (n = 517) included in nine systematic reviews showed that omega-3 supplementation had a non-significant trend toward affecting depressive symptoms in patients with dementia (standardized mean difference (SMD): 0.147; 95% confidence interval (CI): -0.324 to 0.049; p = 0.141). Subgroup analyses revealed that DHA supplementation significantly reduced depressive symptoms (SMD: -0.247; p = 0.039). There was no significant effect for high (SMD: -0.169; 95% CI: -0.454 to 0.116; p = 0.246) or medium (SMD: -0.061; 95% CI: -0.228 to 0.105; p = 0.470) doses of EPA. However, low doses of EPA were significantly effective (SMD: -0.953; 95% CI: -1.534 to -0.373; p = 0.001), with notable improvements in patients with MCI (SMD: -0.934; p < 0.001). The study concludes that omega-3 fatty acids, particularly through DHA supplementation, may alleviate depressive symptoms in patients with MCI. Given the limited sample size, further long-term RCTs are recommended to better understand the efficacy and optimal management of omega-3 supplementation in this population using different dosages.

Unique Dragonfly Hunting Strategies and Exceptionally High Eicosapentaenoic Acid Levels in Brain Lipids: Is There a Link?

Unique Dragonfly Hunting Strategies and Exceptionally High Eicosapentaenoic Acid Levels in Brain Lipids: Is There a Link?

Nutrient and Fatty Acid Composition of Pike Perch (Sander lucioperca) and Evaluation of Important Indexes Related to Human Health

The nutrient and fatty acid composition of the muscle tissues in the dorsal (D), ventral (V), and caudal (C) regions of the pike perch were determined in this study. Pike perch had 19.63% protein, 0.92% lipid, 78.36% moisture, and 1.04% ash. The whole muscle (WM) (0.92%) of pike perch had the highest lipid content, followed by C (0.82%), V (0.73%), and D regions (0.69%). The results of the study revealed that total polyunsaturated fatty acid (PUFA) (32.37%–37.05%) values were higher than those of total saturated fatty acids (SFA) (29.96%–31.76%) and monounsaturated fatty acid (MUFA) (17.26%–20.81%) in all whole muscle (WM) and different regions (D, V, and C) of the pike perch. The highest SFA, MUFA, and PUFA amounts were in D, WM, and D regions, respectively. In all groups, the amount of Docosahexaenoic acid (DHA) (12.97-15.43%) was higher than Eicosapentaenoic acid (EPA) (5.66-6.97%). While there was no difference between regions in terms of EPA value, the difference between regions in terms of DHA values was found to be important (p &amp;lt;0.05). The highest EPA and DHA values were detected in the D region. Atherogenicity index (AI) (0.47–0.48), thrombogenicity index (TI) (0.33–0.35), hypocholesterolemic/hypercholesterolemic ratio (H/H) (1.53–1.57) and n-6/n-3 (0.47–0.51) ratios were at recommended levels in all regions (WM, D, V, and C) and there was no regional difference (p &amp;gt; 0.05). The results showed that the fatty acid composition of the pike perch varies according to different body regions, it is rich in nutrient content and has the recommended level of AI, TI, H/H, and n-6/n-3 ratios. It can be concluded that pike perch has beneficial health effects on human nutrition.

Evaluation of Influencing Factors on Metabolism of Land-Based n-3 Poly Unsaturated Fatty Acids-The KoALA Study.

This study aimed to investigate the impact of influencing factors (sex, eicosapentaenoic acid (EPA) status at baseline, linoleic acid (LA) intake, milk fat intake) on the conversion of α-linolenic acid (ALA) obtained from linseed oil into its long-chain metabolites. In addition, the effect of ALA on cardiovascular risk markers was investigated. This study used a parallel design approach by randomly assigning the 134 subjects to one of four diets (high in LA (HLA); low in LA (LLA); high in milk fat (MF); control (Western diet)) each enriched with linseed oil (10 en%, 22-27 mL ≙ 13-16 g ALA). Blood samples were taken at baseline and after 4, 8, and 12 weeks of dietary intervention. The study was fully completed by 105 subjects (57.4 ± 12.1 years; 65.7% female). Results showed that ALA (296-465%), C-20:4n3 (54-140%), and EPA (37-73%) concentrations in erythrocytes increased in all groups (p < 0.01). In contrast, docosahexaenoic acid (19-35%, p < 0.01) and n-3 index (10-21%, p < 0.05) dropped in the HLA, LLA, and control groups. An increase in C-22:5n3 was only observed in the MF (36%) and control groups (11%) (p < 0.05). In addition, an increase in LA (7-27%) was found in the HLA, LLA, and control groups, whereas C-20:3n6 (16-22%), arachidonic acid (10-16%), C-22:4n6 (12-30%), and C-22:5n6 (32-47%) decreased (p < 0.01). The conversion into EPA was higher in men than in women (69 vs. 39%, p = 0.043) and in subjects with low EPA status compared to participants with high EPA status (79 vs. 29%, p < 0.001). A high LA status attenuates the conversion rate. In line with the literature, no clear effects on blood lipids and parameters of glucose metabolism were found in relation to ALA supplementation.

Meat fatty acids profile including metabolic, qualitative, nutritional indices, and organoleptic evaluation as affected by Rumex nervosus leaves meal fortified broiler diets

The effects of dietary supplementation with Rumex nervosus leaves (RNL) on fatty acid (FAs) indices, organoleptic evaluation, performance index, and feed efficiency were investigated. This study consists of five treatments. Broilers in treatments 1–4 received basal feed plus RNL at doses of 0, 1, 3, and 5 g/kg, while broilers in treatment 5 received basal feed plus the antibiotic Colimex. On day 34, FAs profile and organoleptic assessment were evaluated, and performance index and feed efficiency were determined for the entire experimental period. Results showed that FAs profile of the breast meat was affected by treatments with varying degrees (p˂0.05). The 1 g RNL resulted in the highest eicosapentaenoic acid + docosahexaenoic acid, which resulted in the highest meat lipid quality, the highest elongation index, improved organoleptic characteristics, and tended to improve performance index, feed efficiency, and nutritional index. The 5 g RNL treatment reduced total saturated fatty acids (ƩSFAs), omega-6/omega-3 ratio, especially linoleic acid/α-linolenic acid ratio, alanine aminotransferase, and increased total omega-3 fatty acids, unsaturation index, and Δ9-desaturase. In conclusion, RNL can be introduced to broiler diets, especially at an incorporation rate of 1 g, and it promotes broiler health and performance because it contains phytoconstituents that can alter the content and indices of FAs meat and improve storability and sensory quality.

Predicting Survival Outcomes at Five Years Following Administration of Omega-3 Long-Chain Fatty Acids in People Living with Squamous Cell Carcinoma of the Head and Neck

There is a paucity of research on longer-term outcomes following oral nutrition supplementation (ONS) in patients with cancer. An observational analysis on mortality and survival rates were conducted in patients with head and neck squamous cell carcinoma (HNSCC) that received cancer treatment ONS plus 2 g of eicosapentaenoic-acid (EPA) versus standard treatment (EN). Twenty-six participants were available (81.3% of the original cohort [n=32]) in the ONS-EPA 2 g and 24 (75% of original cohort [n=32]) in the ONS-standard groups. Mortality at five years was 50% in the ONS-EPA 2 g and 58.3% in the ONS-standard group but with longer survival time in the ONS-EPA 2 g than the ONS-standard group (35 versus 18 months, respectively). A trend toward a longer survival time five years was observed in participants who received ONS with a high EPA content compared to those who received standard-formula ONS. Results may represent a possible long-term benefit of using high EPA supplementation during active cancer treatment to address malnutrition and positively influence clinical outcomes. Keywords: Nutritional supplementation, Eicosapentaenoic acid, Head and neck squamous cell carcinoma, 5­year mortality

Environmental drivers alter PUFA content in littoral macroinvertebrate assemblages via changes in richness and abundance

Shallow littoral areas in lakes are productive and highly diverse ecotonal zones, providing habitats for both invertebrate and vertebrate species. We developed a Bayesian modeling framework to elucidate the relationships between environmental drivers (lake typology, habitat, water chemistry, and latitude) and taxon richness, abundance, as well as the content of polyunsaturated fatty acids (PUFAs) in littoral macroinvertebrate communities in 95 boreal lakes. PUFAs, particularly arachidonic acid (ARA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), are critical micronutrients to maintain normal physiological functions in consumers. Lake typology was a significant predictor for PUFA content in the invertebrate assemblages, which was connected to taxon richness and/or abundance. Benthic communities in large humus-poor or nutrient-rich lakes displayed higher abundance, taxon richness, and more PUFA-rich taxa, whereas those in medium- and large-sized humic (color 30–90 mg Pt/L) and humus-rich lakes (color >90 mg Pt/L) were characterized by decreased abundance and subsequently low PUFA content. The abundance, taxon richness, and nutritional quality of the communities were also strongly related to latitude. Lakes with lower pH were characterized by lower benthic invertebrate diversity and low frequency of taxa with high somatic EPA and DHA content. The complexity of littoral habitats dominated by various macrophyte assemblages creates an environment that favors higher benthic abundance and increased presence of taxonomic groups with high PUFA content. Nutritional quality of benthic invertebrates for upper trophic levels can be modulated by a complex interplay between external stressors and abiotic factors that typically shape the structure of littoral benthic communities.

Análisis proximal y perfil de ácidos grasos de los tejidos musculares en diferentes partes del cuerpo del barbo de Crimea (Barbus tauricus Kessler, 1877)

This study aimed to determine proximate analysis and fatty acid profile of whole body muscle tissue (WM) and muscles in different parts of the body, including dorsal (D), ventral (V), and caudal (C) regions, of the crimean barbel (Barbus tauricus), which is an species caught from the Gelingüllü Dam. In whole body muscle the protein, lipid, moisture, and ash contents of the fish were 18.61, 1.54, 78.49, and 1.09% respectively. The lipid contents of crimean barbel varied between 1.78 and 2.68%, with the highest and lowest percentages in the C and V regions, respectively. There was a significant difference (P&lt;0.05) in the fatty acid content present in the different parts of the fish. The highest and lowest proportions of saturated fatty acids (SFA) were found in WM (23.03) and D (21.94%) region, respectively. The highest and lowest monounsaturated fatty acid (MUFA) contents were found in the D muscle (36) and V muscles (33.73%), respectively. The proportion of polyunsaturated fatty acids (PUFA) was highest and lowest in C (25.63) and D (22.62%) regions, respectively. The highest eicosapentaenoic acid (4.11) and docosahexaenoic acid (12.98%) contents were found in V and C regions, respectively. The results showed that lipid content and composition of fatty acids may vary in the different body parts of the fish.

The impact of varying EPA:DHA ratio on Atlantic salmon health and welfare

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are essential fatty acids (EFA) vital for Atlantic salmon health, growth performance, and product quality. Yet, DHA and especially EPA are in short supply as ingredients for aquafeeds. Whilst the role of EFA in salmonid nutrition has been well studied, clear guidelines for aquaculture nutrition practitioners are still missing. This article addresses this gap by testing different EPA:DHA ratios (0.15, 0.55, and 0.98) when these two EFA represent at least 10% of the total pool of fatty acids in aquafeeds. Grow-out trials revealed no differences in zootechnical performance between fish fed the different diets during the initial eight weeks before vaccination challenge, nor on the subsequent three weeks post-vaccination for fish truly vaccinated or sham vaccinated (used as control groups for each of the three diets tested). Nonetheless, the FCR of vaccinated fish was significantly higher than sham vaccinated conspecifics, but diet yielded no significant effect. The expression of most genes screened (e.g., Elongation Factor 1α (Elf-1α), Interleukin 10 (IL10), Interleukin 8 (IL8), Tumor Necrosis Factor (TNFα)) was not significantly affected by vaccination or diet, while Viperine and Mx genes were upregulated in sham vaccinated fish fed the experimental diet with an EPA:DHA ratio of 0.55. The fatty acid composition of head kidney was affected by diet, namely EPA, but not DHA. The fatty acid profile of white muscle was also significantly affected by diet, with contrasting results for EPA and DHA; EPA content was higher for fish fed diets with higher EPA:DHA ratios and DHA levels were significantly higher (peaking at 16% of the total pool of fatty acids) when fish were provided with the diet featuring the lowest EPA:DHA ratio (0.15). Interestingly, fish fed the diet with the highest EPA:DHA ratio showed a lower number of wounded fish at the end of the grow-out period post-vaccination. Despite the reduction was not statistically significant, given the severe impact of wounded fish on salmon farming productivity, our results indicate that the partial replacement of fish oil with algal oil in salmon feed contributed to achieving a balanced EPA:DHA ratio, an adequate profile of Omega-3 long chain polyunsaturated fatty acids and improved the overall health and welfare of fish. This approach creates the opportunity to increase the productivity of fish farming operations and foster a more sustainable growth of the aquaculture industry.

Metabolic analysis of Schizochytrium sp. mutants with high EPA content achieved with ARTP mutagenesis screening.

Eicosapentaenoic acid (EPA) belonged to the ω-3 series of polyunsaturated fatty acids and had physiological functions lipid as regulating blood lipid and preventing cardiovascular diseases. Schizochytrium sp. was considered to be a potential industrial fermentation strain of EPA because of its fast growth, high oil content, and simple fatty acid composition. However, Schizochytrium sp. produced EPA with low production efficiency and a long synthesis path. This research aims to improve the yield of EPA in Schizochytrium sp. by ARTP mutagenesis and to reveal the mechanism of high-yield EPA through transcriptome analysis. ARTP mutagenesis screening yielded the mutant M12 that whereas the productivity of EPA increased 108% reaching 0.48g/L, the total fatty acid concentration was 13.82g/L with an increase of 13.7%. The transcriptomics revealed 2995 differentially expressed genes were identified between M12 and the wild-type strain and transcripts involved in carbohydrate, amino acid, energy, and lipid metabolism were up-regulated. Among them, the hexokinase (HK) and the phosphofructokinase genes (PFK), which can catalyze pyruvate to acetyl-CoA, were increased 2.23-fold and 1.78-fold. Glucose-6-phosphate dehydrogenase (G6PD) and glutamate dehydrogenase (GLDH), which can both generate NADPH, were increased by 1.67-fold and 3.11-fold. Furthermore, in the EPA synthesis module, the expression of 3-oxoacyl-[acyl-carrier protein] reductase(fabG) and carbonyl reductase 4 / 3-oxoacyl-[acyl-carrier protein] reductase beta subunit(CBR4), also up-regulated 1.11-fold and 2.67-fold. These may lead to increases in cell growth. The results provide an important reference for further research on promoting fatty acid and EPA accumulation in Schizochytrium sp.

Dietary Fats and Depressive Symptoms in Italian Adults.

Depression represents one of the major causes of disability worldwide, with an important socioeconomic cost. Although many risk factors have been considered in its pathogenesis, nutrition seems to play a determinant role in its prevention. With regard to individual macronutrients, dietary fats and especially n-3 polyunsaturated fatty acids (n-3 PUFA) are the most studied. However, previous data about other dietary fatty acids, such as n-6 PUFA, are conflicting, and little is known about saturated fatty acids (SFA), especially when considering carbon chain length. Thus, we investigated whether single types and subtypes of dietary fats are related to depressive symptoms in Italian individuals living in the Mediterranean area. Dietary and socio-demographic data of 1572 individuals were analyzed. Food frequency questionnaires (FFQs) were used to determine the consumption of total dietary fat and each specific class of dietary fat, such as SFA, monounsaturated fatty acid (MUFA), and PUFA. The intake of fatty acids was also assessed according to the carbon-chain length of each single class. The Center for Epidemiologic Studies Depression Scale (CES-D) was used as a screening tool for depressive symptoms. After adjustment for potential confounding factors, a significant inverse association between low/moderate levels of PUFA intake and depressive symptoms (Q2 vs. Q1, odds ratio (OR) = 0.60, 95% CI: 0.44, 0.84) was found. On the other hand, moderate saturated fat consumption was associated with depressive symptoms (Q3 vs. Q1, OR = 1.44, 95% CI: 1.02, 2.04). However, when considering carbon chain length, individuals with a lower to moderate intake of short-chain saturated fatty acids (SCSFA) and medium-chain saturated fatty acids (MCSFA) were less likely to have depressive symptoms (Q3 vs. Q1, OR = 0.48, 95% CI: 0.31, 0.75), while moderate intake of arachidic acid (C20:0) was directly associated with depressive symptoms (Q3 vs. Q1, OR = 1.87, 95% CI: 1.26, 2.77). Among single MUFAs, higher myristoleic acid (C14:1) intake was directly associated with depressive symptoms (Q4 vs. Q1, OR = 1.71, 95% CI: 1.12, 2.61), while moderate intake of erucic acid (C22:1) was associated with lower odds of having depressive symptoms (Q3 vs. Q1, OR = 0.54, 95% CI: 0.33, 0.86). When considering individual PUFAs, individuals with moderate and higher intakes of arachidonic acid (C20:4) were less likely to have depressive symptoms (OR = 0.64, 95% CI: 0.45, 0.91; OR = 0.59, 95% CI: 0.38, 0.91, respectively). Similarly, higher eicosapentaenoic acid (C20:5) intake was inversely associated with depressive symptoms (Q4 vs. Q1, OR = 0.35, 95% CI: 0.12, 0.98), while a significant association for docosahexaenoic acid (C22:6) was retrieved only for low intakes (Q2 vs. Q1, OR = 0.33, 95% CI: 0.12, 0.88). Dietary fat intake may be associated with depressive symptoms, underlying the importance of distinguishing between different fat types. This study confirms the pivotal role of PUFAs and reopens the debate on the role of saturated fatty acids, suggesting plausible effects of moderate intakes of short-chain fatty acids.

Associations of eicosapentaenoic acid and docosahexaenoic acid intakes with cardiovascular and all-cause mortality in patients with diabetes: Result from National Health and Nutrition Examination Survey 1999-2008.

The evidence on eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake status and long-term mortality among people with diabetes is scarce. This study aimed to investigate the relationship between EPA and DHA intakes with all-cause and cause-specific mortality in adults with diabetes. This study included 2,991 adults with diabetes from the National Health and Nutrition Examination Survey (NHANES) 1999-2008. Death outcomes were ascertained by linkage to the database records through 31 December 2015. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality from all causes, cardiovascular disease (CVD), and coronary heart disease (CHD) in patients with diabetes. Among 2,991 patients with diabetes, the mean age was 61.9 years (55.2% males). During the mean follow-up duration of 9.4 years, a total of 1,091 deaths were documented, of which 273 were due to CVD, including 227 CHD deaths. EPA and DHA intakes were associated with lower mortality risks, especially that of CVD. After adjusting for demographic, major lifestyle factors, overall dietary intake patterns, and history of hypertension and dyslipidemia, the multivariable HRs (95% CIs) of mortality risk comparing Q4 to Q1 of EPA intake were 0.55 (0.33-0.92; P-trend = 0.019) for CHD, 0.55 (0.36-0.83; P-trend = 0.005) for CVD, and 0.91 (0.70-1.18; P-trend = 0.264) for all-cause. The respective HRs (95% CIs) comparing Q4 to Q1 of DHA were 0.60 (0.37-0.98; P-trend = 0.051) for CHD, 0.58 (0.38-0.89; P-trend = 0.014) for CVD, and 0.92 (0.72-1.18; P-trend = 0.481) for all-cause. In subgroup analysis, we found that the association trends of EPA and DHA intakes with death risk remained robust among patients with diabetes, especially among those who are old, female, those with higher BMI, and dyslipidemia patients with CVD and CHD. In the USA, higher EPA and DHA intakes were associated with a lower risk of CHD and CVD mortality in patients with diabetes. Our study supports the benefits of adequate EPA and DHA intakes in promoting the health of patients with diabetes.

Lipidomes of Icelandic bryophytes and screening of high contents of polyunsaturated fatty acids by using lipidomics approach

Bryophytes (mosses, liverworts, and hornworts) have interested researchers because of their high chemical diversity and their potential uses in pharmaceutical, food, and cosmetic industries. Specifically, long-chain polyunsaturated fatty acids (l-PUFA) such as arachidonic acid (AA) and eicosapentaenoic acid (EPA) are commonly found in bryophytes, but not in vascular plants. Bryophytes accumulate PUFAs in cold or even freezing temperature to keep the cell fluidity. Iceland has a long history of bryophyte vegetation. These bryophytes are highly adapted to the harsh environment in Iceland and therefore are expected to produce high amounts of PUFAs. However, despite the fact that hundreds of mosses and liverworts have been found in Iceland, their lipid profiles largely remain unknown. In this study, we performed untargeted lipidomics by using UPLC-ESI-QTOF-MS as a rapid screening strategy to examine the lipid compositions of 39 local bryophyte species in Iceland and aimed to find high AA and EPA producers. A total of 280 lipid molecular species from 15 lipid classes were quantified with isotope-labeled internal standards. AA and EPA were abundantly distributed in the phospholipids (mainly PC and PE) and glycerolipids (MGDG and DGDG) in six moss species, namely Racomotrium lanuginosum, R. ericoides, Bryum psedotriquetrium, Plagiomnium ellipticum, Hylocomium splendens, and Rhytidiadelphus triquetrus. Two of the six species (B. psedotriquetrium and H. splendens) also accumulated high concentrations of PUFA-containing-triacylglycerols.